Search tips
Search criteria 


Logo of hsresearchLink to Publisher's site
Health Serv Res. 1985 June; 20(2): 163–182.
PMCID: PMC1068873

The hepatitis B vaccine: utilization decision process and outcomes in community hospitals.


The process by which administrators, physicians, and other health professionals develop decisions on the adoption of innovations was examined through a study of the decision process relating to the institutional use of a vaccine to prevent hepatitis B. Mail questionnaires and telephone follow-up interviews were used to collect data on the decision process in 56 Arizona hospitals in 1983 and 1984. A five-stage decision process was employed by the institutions. Critical stages in the process involved defining who would make the adoption decision and the collection of information related to the innovation. The institutional plans for vaccine distribution did not exhibit a clear consensus regarding the identification of high-risk employee groups. Employee acceptance of the vaccine, even with the cost paid by the hospital, was limited.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Foster RW. Cost-based reimbursement and prospective payment: reassessing the incentives. J Health Polit Policy Law. 1982 Summer;7(2):407–420. [PubMed]
  • Cohodes DR. Which will survive? The $150 billion capital question. Inquiry. 1983 Spring;20(1):5–11. [PubMed]
  • Cohodes DR. Hospital capital formation in the 1980s: is there a crisis? J Health Polit Policy Law. 1983 Spring;8(1):164–172. [PubMed]
  • Denes AE, Smith JL, Maynard JE, Doto IL, Berquist KR, Finkel AJ. Hepatitis B infection in physicians. Results of a nationwide seroepidemiologic survey. JAMA. 1978 Jan 16;239(3):210–212. [PubMed]
  • Pantelick EL, Steere AC, Lewis HD, Miller DJ. Hepatitis B infection in hospital personnel during an eight-year period; policies for screening and pregnancy in high risk areas. Am J Med. 1981 Apr;70(4):924–927. [PubMed]
  • Pattison CP, Maynard JE, Berquist DR, Webster HM. Epidemiology of hepatitis B in hospital personnel. Am J Epidemiol. 1975 Jan;101(1):59–64. [PubMed]
  • Osterholm M, Andrews JS., Jr Viral hepatitis in hospital personnel in Minnesota. Report of a statewide survey. Minn Med. 1979 Sep;62(9):683–689. [PubMed]
  • Schneider WJ. Hepatitis B: an occupational hazard of health care facilities. J Occup Med. 1979 Dec;21(12):807–810. [PubMed]
  • Bond WW, Petersen NJ, Favero MS. Viral hepatitis B: aspects of environmental control. Health Lab Sci. 1977 Oct;14(4):235–252. [PubMed]
  • Seeff LB, Hoofnagle JH. Immunoprophylaxis of viral hepatitis. Gastroenterology. 1979 Jul;77(1):161–182. [PubMed]
  • Grady GF, Lee VA, Prince AM, Gitnick GL, Fawaz KA, Vyas GN, Levitt MD, Senior JR, Galambos JT, Bynum TE, et al. Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis. 1978 Nov;138(5):625–638. [PubMed]
  • Hoofnagle JH, Seeff LB, Bales ZB, Wright EC, Zimmerman HJ. Passive-active immunity from hepatitis B immune globulin. Reanalysis of a Veterans Administration cooperative study of needle-stick hepatitis. The Veterans Administration Cooperative Study Group. Ann Intern Med. 1979 Dec;91(6):813–818. [PubMed]
  • Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833–841. [PubMed]
  • Gerety RJ, Tabor E. Newly licensed hepatitis B vaccine. Known safety and unknown risks. JAMA. 1983 Feb 11;249(6):745–746. [PubMed]
  • Baker CH, Brennan JM. Keeping health-care workers healthy. Legal aspects of hepatitis B immunization programs. N Engl J Med. 1984 Sep 6;311(10):684–688. [PubMed]
  • Dandoy SE, Kirkman-Liff BL, Krakowski FM. Hepatitis B exposure incidents in community hospitals. Am J Public Health. 1984 Aug;74(8):804–807. [PubMed]
  • Kirkman-Liff B, Dandoy S. Cost of hepatitis B prevention in hospital employees: post-exposure prophylaxis. Infect Control. 1984 Aug;5(8):385–389. [PubMed]
  • Kaluzny AD. Innovation in health services: Theoretical framework and rewiew of research. Health Serv Res. 1974 Summer;9(2):101–120. [PMC free article] [PubMed]
  • Kimberly JR. Hospital adoption of innovation: the role of integration into external informational environments. J Health Soc Behav. 1978 Dec;19(4):361–373. [PubMed]
  • Georgopoulos BS. Organizational rationality, medicine, and the use of new knowledge in American hospitals. Hosp Health Serv Adm. 1982 May-Jun;27(3):34–56. [PubMed]
  • Brozovich JP, Loftus DG. Physician-administrator decision making for high-technology purchases: a model approach. Health Care Manage Rev. 1981 Summer;6(3):63–73. [PubMed]
  • Nathanson CA, Morlock LL. Control structure, values, and innovation: a comparative study of hospitals. J Health Soc Behav. 1980 Dec;21(4):315–333. [PubMed]
  • Kaluzny AD, Veney JE, Gentry JT. Innovation of health services: a comparative study of hospitals and health departments. Milbank Mem Fund Q Health Soc. 1974 Winter;52(1):51–82. [PubMed]
  • Reed JS, Anderson AC, Hodges GR. Needlestick and puncture wounds: definition of the problem. Am J Infect Control. 1980 Nov;8(4):101–106. [PubMed]
  • Jacobson JT, Burke JP, Conti MT. Injuries of hospital employees from needles and sharp objects. Infect Control. 1983 Mar-Apr;4(2):100–102. [PubMed]

Articles from Health Services Research are provided here courtesy of Health Research & Educational Trust